AMG 596, a novel anti-EGFRvIII bispecific T cell engager (BiTE®) molecule for the treatment of glioblastoma (GBM): Planned interim analysis in recurrent GBM (rGBM) Meeting Abstract
| Authors: | Rosenthal, M. A.; Balana, C.; van Linde, M. E.; Sayehli, C.; Fiedler, W. M.; Wermke, M.; Massard, C.; Mellinghoff, I. K.; Khasraw, M.; Ang, A.; Rasmussen, E.; Kast, J.; Stienen, S.; Cloughesy, T. F. |
| Abstract Title: | AMG 596, a novel anti-EGFRvIII bispecific T cell engager (BiTE®) molecule for the treatment of glioblastoma (GBM): Planned interim analysis in recurrent GBM (rGBM) |
| Meeting Title: | 3rd SNO-SCIDOT Joint Conference on Therapeutic Delivery to the CNS |
| Journal Title: | Neuro-Oncology |
| Volume: | 21 |
| Issue: | Suppl. 6 |
| Meeting Dates: | 2019 Nov 20-21 |
| Meeting Location: | Phoenix, AZ |
| ISSN: | 1522-8517 |
| Publisher: | Oxford University Press |
| Date Published: | 2019-11-01 |
| Start Page: | vi283 |
| Language: | English |
| ACCESSION: | WOS:000509478706200 |
| PROVIDER: | wos |
| DOI: | 10.1093/neuonc/noz219.1195 |
| PMCID: | PMC6873614 |
| Notes: | Meeting Abstract: ATIM-49 (LTBK-01) -- Source: Wos |
